1. Home
  2. ANNX

as 03-28-2025 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Founded: 2011 Country:
United States
United States
Employees: N/A City: BRISBANE
Market Cap: 362.4M IPO Year: 2020
Target Price: $15.80 AVG Volume (30 days): 1.6M
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.01 EPS Growth: N/A
52 Week Low/High: $2.18 - $7.85 Next Earning Date: 03-03-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

ANNX Daily Stock ML Predictions

Stock Insider Trading Activity of Annexon Inc. (ANNX)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Lew Jennifer ANNX EVP & CHIEF FINANCIAL OFFICER Feb 18 '25 Sell $2.92 6,912 $20,183.04 77,770
Overdorf Michael ANNX EVP & CHIEF BUSINESS OFFICER Feb 18 '25 Sell $2.95 6,618 $19,523.10 86,579
Dananberg Jamie ANNX CHIEF MEDICAL OFFICER Feb 18 '25 Sell $2.96 5,521 $16,342.16 33,479
ARTIS DEAN RICHARD ANNX EVP & CHIEF SCIENTIFIC OFFICER Feb 18 '25 Sell $2.97 5,515 $16,379.55 83,814
Yednock Ted ANNX EVP & CHIEF INNOVATION OFFICER Feb 18 '25 Sell $2.91 8,345 $24,283.95 61,237
Lew Jennifer ANNX EVP & CHIEF FINANCIAL OFFICER Feb 13 '25 Sell $2.98 1,786 $5,322.28 77,770
Overdorf Michael ANNX EVP & CHIEF BUSINESS OFFICER Feb 13 '25 Sell $2.99 1,425 $4,260.75 86,579
Yednock Ted ANNX EVP & CHIEF INNOVATION OFFICER Feb 13 '25 Sell $2.99 1,783 $5,331.17 61,237
Love Douglas ANNX PRESIDENT AND CEO Feb 13 '25 Sell $2.95 5,021 $14,811.95 351,554

Share on Social Networks: